Home › Research › Mild cognitive impairment
Association of Favorable Cerebrospinal Fluid Markers With Reversion of Mild Cognitive Impairment Due to Parkinson’s Disease
Cameron A. Ryczek, Rhiannon Rivas, Lea Hemphill, Zackary Zanotelli, Nicholas Renteria, Khashayar Dashtipour, Jacob D. Jones. Journal of Neuropsychiatry, 2025-01-10
Topic: Brain proteins, microglia and lab models
Plain-language summary
The PD-MCI nonreversion group had greater p-tau:amyloid beta and t-tau:amyloid beta ratios relative to the PD-MCI reversion group. The CN and PD-MCI reversion groups did not significantly differ in any of the CSF markers. PD-MCI reverters may have a more favorable trajectory in terms of AD pathology relative to PD-MCI nonreverters. Future studies are needed to verify whether PD-MCI reversion may represent an intermediate prognostic group between CN individuals and those with MCI nonreversion.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 430 participants. This longitudinal study found that people with Parkinson's disease and mild cognitive impairment who reverted to normal cognition had more favorable cerebrospinal fluid markers of Alzheimer's disease pathology than those who did not revert. It describes a prognostic difference and does not test any treatment, cure, or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Ryczek, C. A., Rivas, R., Hemphill, L., Zanotelli, Z., Renteria, N., Dashtipour, K., et al. (2025). Association of Favorable Cerebrospinal Fluid Markers With Reversion of Mild Cognitive Impairment Due to Parkinson’s Disease. Journal of Neuropsychiatry. https://doi.org/10.1176/appi.neuropsych.20240099
Vancouver
Ryczek CA, Rivas R, Hemphill L, Zanotelli Z, Renteria N, Dashtipour K, et al. Association of Favorable Cerebrospinal Fluid Markers With Reversion of Mild Cognitive Impairment Due to Parkinson’s Disease. Journal of Neuropsychiatry. 2025. doi:10.1176/appi.neuropsych.20240099. PMID: 39789939.
BibTeX
@article{ryczek2025-39789939,
author = {Ryczek, Cameron A. and Rivas, Rhiannon and Hemphill, Lea and Zanotelli, Zackary and Renteria, Nicholas and Dashtipour, Khashayar and Jones, Jacob D.},
title = {{Association of Favorable Cerebrospinal Fluid Markers With Reversion of Mild Cognitive Impairment Due to Parkinson’s Disease}},
journal = {Journal of Neuropsychiatry},
year = {2025},
doi = {10.1176/appi.neuropsych.20240099},
pmid = {39789939},
url = {https://doi.org/10.1176/appi.neuropsych.20240099}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- The PD-MCI nonreversion group had greater p-tau:amyloid beta and t-tau:amyloid beta ratios relative to the PD-MCI reversion group.
- The CN and PD-MCI reversion groups did not significantly differ in any of the CSF markers.
- PD-MCI reverters may have a more favorable trajectory in terms of AD pathology relative to PD-MCI nonreverters.
- Future studies are needed to verify whether PD-MCI reversion may represent an intermediate prognostic group between CN individuals and those with MCI nonreversion.
Why it matters
This longitudinal study found that people with Parkinson's disease and mild cognitive impairment who reverted to normal cognition had more favorable cerebrospinal fluid markers of Alzheimer's disease pathology than those who did not revert. It describes a prognostic difference and does not test any treatment, cure, or prevention.
Study details
- Study designlongitudinal study
- Participants430
- Evidence strengthModerate
How this study scored 49/100
Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of Neuropsychiatry) |
| Journal's citation record | 2 / 4 | Journal of Neuropsychiatry: journal h-index 155 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 430 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 2 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Jacob D. Jones: h-index 22 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Loma Linda University: institution h-index 401 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39789939) |
| Free to read | 2 / 2 | Free to read |
| Total | 49 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1176/appi.neuropsych.20240099
- PubMed: 39789939
- Original source →
- Free full text: Europe PMC (PubMed Central) →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Mild cognitive impairment from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.